Emotional distress and quality of life in allergic diseases

Emotional disorders accompany many somatic diseases, especially ones with severe or chronic course, and such are allergic diseases. Long-term course of the disease, the need for chronic treatment and repeated exacerbations as well as symptoms of depression or anxiety have a significant impact on the quality of life of patients, constituting a serious burden both from the point of view of the individual and the society. The data evaluating emotional disturbances and their impact on the quality of life in three atopic diseases: bronchial asthma, atopic dermatitis and seasonal rhinitis were analysed. Mood disorders as well as mental and behavioral disorders due to alcohol abuse are the most common psychiatric disorders observed in patients with bronchial asthma. There are data indicating a relationship between the occurrence of allergic rhinitis and mood disorders, anxiety disorders and suicidal tendencies. Atopic dermatitis is associated with an increased risk of depressive and anxiety disorders and sleep disorders, and in children with more prevalence of behavioral disorders. Most studies highlighted the relationship between emotional disorders and quality of life in the above-mentioned patient groups. In addition to physical ailments, patients suffering from allergic diseases also report emotional problems that can adversely affect the course of the disease, the treatment process, and reduce quality of life. Therefore, these patients require a holistic approach with a more accurate assessment of emotional disorders.

Download Full-text

Cognitive-Behavioral Group Therapy for Heterogeneous Anxiety and Mood Disorders in a Psychiatric Hospital Outpatient Clinic

Journal of Cognitive Psychotherapy ◽

10.1891/0889-8391.27.2.138 ◽

2013 ◽

Vol 27 (2) ◽

pp. 138-154 ◽

Cited By ~ 9

Author(s):

Lynndall Dwyer ◽

Sara Olsen ◽

Tian Po S. Oei

Keyword(s):

Quality Of Life ◽

Anxiety Disorders ◽

Mood Disorders ◽

Outcome Measures ◽

Depressive Disorders ◽

Behavioral Therapy ◽

Cognitive Behavioral ◽

Cognitive Behavioral Group Therapy ◽

Group Cbt

Recent literature has shown that group cognitive-behavioral therapy (CBT) is effective for individuals with heterogeneous anxiety disorders. However, these studies have used a narrow range of outcome measures, and have not included global measures such as quality of life. In addition, heterogeneous mood disorders have not been well researched. The aim of this study was to replicate and extend on previous studies by assessing the effectiveness of group CBT treatment programs designed for use with heterogeneous anxiety or depressive disorders. Global outcome measures of quality of life and social functioning were assessed in addition to outcome measures of anxiety and mood symptoms. There were 173 patients who completed either group CBT for anxiety disorders or for depressive disorders. Symptom measures and quality of life measures were used to determine treatment effectiveness. Results demonstrated that the treatments were effective in reducing overall symptom severity and improving quality of life. Treatment gains were maintained to 12 month follow-up. However, the degree of change was considerably lower than that found in comparable trials with diagnostically homogenous samples. Overall, group CBT for heterogeneous diagnostic populations was effective but requires further investigation and refinement.

Download Full-text

An overview of allergy and sinusitis

South African Family Practice ◽

10.4102/safp.v59i5.4746 ◽

2017 ◽

Vol 59 (3) ◽

pp. 20-28

Author(s):

Nicholus Magongwa ◽

Natalie Schellack

Keyword(s):

Quality Of Life ◽

Atopic Dermatitis ◽

Allergic Conjunctivitis ◽

Allergic Diseases ◽

Comorbid Conditions ◽

Management Options ◽

Current Management ◽

Duration Of Therapy ◽

The People

Allergic diseases affect many people across the globe. They are considered to significantly disturb the quality of life of the people who are affected, creating personal and economic predicaments. Some of the most commonly diagnosed allergic diseases include atopic dermatitis, rhinitis, allergic conjunctivitis and sinusitis. Some conditions, such as eosinophilic esophagitis, are on the rise and are being diagnosed across all continents except for Africa. The use of antihistamines has been the mainstay of therapy for most allergic conditions, except for other conditions that require corticosteroids, or in severe allergic conditions such as anaphylaxis where antihistamines are ineffective as main therapy. It is important to consider first versus second-generation options when treating allergic diseases, also bearing in mind the duration of therapy and any comorbid conditions that a patient might have. This article provides an overview of these conditions and their current management options.

Download Full-text

Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders

Anais Brasileiros de Dermatologia ◽

10.1590/abd1806-4841.20131915 ◽

2013 ◽

Vol 88 (6) ◽

pp. 894-899 ◽

Cited By ~ 19

Author(s):

Ana Paula Dornelles da Silva Manzoni ◽

Magda Blessmann Weber ◽

Aline Rodrigues da Silva Nagatomi ◽

Rita Langie Pereira ◽

Roberta Zaffari Townsend ◽

...

Keyword(s):

Quality Of Life ◽

Atopic Dermatitis ◽

Emotional Disorders ◽

Pediatric Patients ◽

Skin Diseases ◽

Anxiety And Depression ◽

Depression And Anxiety ◽

Skin Disorders ◽

Chronic Skin

BACKGROUND: The literature has shown that the presence of emotional disturbances in caregivers of children with skin diseases affects the course and treatment of the disease. Anxiety and depression are among the most frequently reported psychiatric diagnoses related to this fact. OBJECTIVE: To evaluate the presence of anxiety and depression in caregivers of pediatric patients with chronic skin disorders, exemplified by atopic dermatitis, psoriasis and vitiligo, and correlate them to the quality of life of the patients. METHODS: The sample consisted of 118 patients with atopic dermatitis, vitiligo and psoriasis, monitored by their main caregiver. The levels of anxiety and depression in the caregivers were assessed using the Hamilton Anxiety Scale and the Beck Depression Inventory, respectively. The Children's Dermatology Life Quality Index was applied. RESULTS: Anxiety was observed in 36% of the caregivers of the patients with atopic dermatitis, in 36% of those of children affected by psoriasis, and in 42% of those responsible for pediatric patients with vitiligo. Depression occurred in 36% of the caregivers of patients with atopic dermatitis, in 36% of those of children affected by psoriasis and in 26% of those responsible for pediatric patients with vitiligo. There was a significant correlation between poor quality of life scores in patients with vitiligo and the presence of depression and anxiety in their caregivers. CONCLUSION: Emotional disorders tend to be present among close family members of children with the chronic skin diseases studied and their prevention can help in controlling and treating these diseases.

Download Full-text

Clinical efficacy of anti-ige-therapy in adult patients with severe uncontrolled bronchial asthma in real clinical practice

Medical Council ◽

10.21518/2079-701x-2018-15-54-58 ◽

2018 ◽

pp. 54-58

Author(s):

G. L. Ignatova ◽

E. V. Blinova ◽

O. L. Minakina

Keyword(s):

Quality Of Life ◽

Clinical Practice ◽

Bronchial Asthma ◽

Allergic Diseases ◽

Adult Patients ◽

Asthma Exacerbations ◽

Ige Mediated ◽

Real Clinical Practice

The article presents the results of comprehensive assessment of the efficacy of anti-IgE therapy in adult patients with severe IgE-mediated uncontrolled bronchial asthma in real clinical practice. Omalizumab added to the background anti-inflammatory therapy allowed to reduce the incidence of asthma exacerbations, achieve stable positive dynamics during severe asthma and associated allergic diseases, increase control of the disease, and improve the patients’ quality of life. The drug has a wellcharacterized long-term use safety profile.

Download Full-text

VITAMIN D AND ALLERGIC DISEASES IN CHILDREN

Российский педиатрический журнал ◽

10.18821/1560-9561-2017-20-3-166-172 ◽

2019 ◽

Vol 20 (3) ◽

pp. 166-172 ◽

Cited By ~ 4

Author(s):

Galina I. Smirnova ◽

R. E. Rumyantsev

Keyword(s):

Quality Of Life ◽

Vitamin D ◽

Immune Response ◽

Atopic Dermatitis ◽

Allergic Inflammation ◽

Allergic Diseases ◽

Biological Properties ◽

Therapeutic Strategies ◽

Sick Children

There are presented data on the participation of vitamin D in the formation of various forms of allergic pathology in children. The spectrum of knowledge about the biological properties of vitamin D has recently expanded significantly. There are described peculiarities of metabolism of vitamin D and its participation in the leading links of the pathogenesis of atopic dermatitis (AD): in the regulation of the immune response, violations of the integrity of the epidermal barrier and the realization of allergic inflammation in the skin. The pathogenetic significance of vitamin D deficiency in the formation of bronchial asthma (BA) is discussed. Possibilities of the use of vitamin D and its analogues in AD and BA patients are indicated. The authors believe the compensation for vitamin D (hormone) D deficiency in allergic pathology to be an important preventive and curative task within the framework of therapeutic strategies aimed at improving the quality of life of sick children.

Download Full-text

Quality of Life in Heterogeneous Anxiety Disorders: Changes Across Cognitive-Behavioral Treatments

Behavior Modification ◽

10.1177/0145445518815603 ◽

2018 ◽

Vol 44 (3) ◽

pp. 343-364

Author(s):

Julianne G. Wilner ◽

Steven Dufour ◽

Katherine Kennedy ◽

Shannon Sauer-Zavala ◽

Hannah Boettcher ◽

...

Keyword(s):

Quality Of Life ◽

Anxiety Disorders ◽

Emotional Disorders ◽

Controlled Trial ◽

Diagnostic Category ◽

Cognitive Behavioral ◽

Behavioral Treatments ◽

Treatment Research

Quality of life is lower among individuals with anxiety disorders; however, this construct is rarely a focus in treatment research. This study explores changes in quality of life in a randomized, controlled trial of several cognitive-behavioral treatments (CBTs) for anxiety disorders. Adults with heterogeneous anxiety disorders ( N = 223) were randomly assigned to (a) unified protocol for transdiagnostic treatment of emotional disorders, (c) a single-disorder protocol targeting their principal diagnosis, or (c) a waitlist control condition, and assessed at baseline, posttreatment, and 6-month follow-up. At baseline, the sample evidenced deficits in quality of life, with no significant differences in quality of life across diagnoses or condition. Results suggest improved quality of life among participants in treatment, at similar rates across treatment condition and diagnostic category, and at levels significantly higher than the waitlist. Improvements were maintained through 6-month follow-up. This study supports CBT as effective in promoting quality of life.

Download Full-text